Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1878 1
1945 1
1946 3
1947 8
1948 4
1950 6
1951 8
1952 4
1953 8
1954 7
1955 11
1956 8
1957 9
1958 4
1959 13
1960 11
1961 14
1962 13
1963 16
1964 18
1965 17
1966 11
1967 19
1968 20
1969 16
1970 33
1971 36
1972 28
1973 26
1974 20
1975 33
1976 31
1977 46
1978 43
1979 61
1980 49
1981 35
1982 35
1983 36
1984 45
1985 58
1986 64
1987 66
1988 56
1989 36
1990 58
1991 54
1992 65
1993 73
1994 85
1995 74
1996 100
1997 84
1998 105
1999 102
2000 106
2001 142
2002 149
2003 122
2004 144
2005 196
2006 244
2007 257
2008 310
2009 305
2010 400
2011 401
2012 406
2013 486
2014 627
2015 776
2016 829
2017 786
2018 910
2019 939
2020 1108
2021 1094
2022 1076
2023 1052
2024 485

Text availability

Article attribute

Article type

Publication date

Search Results

13,581 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for simon cancer
Search for Simón Cancela instead (1 results)
Colorectal cancer development and advances in screening.
Simon K. Simon K. Clin Interv Aging. 2016 Jul 19;11:967-76. doi: 10.2147/CIA.S109285. eCollection 2016. Clin Interv Aging. 2016. PMID: 27486317 Free PMC article. Review.
This has allowed for screening and detection of early-stage precancerous polyps before they become cancerous in individuals at average risk for colorectal cancer (CRC), which may lead to substantial decreases in the incidence of CRC. Despite the known benefits of ea …
This has allowed for screening and detection of early-stage precancerous polyps before they become cancerous in individuals at averag …
Glutathione metabolism in cancer progression and treatment resistance.
Bansal A, Simon MC. Bansal A, et al. J Cell Biol. 2018 Jul 2;217(7):2291-2298. doi: 10.1083/jcb.201804161. Epub 2018 Jun 18. J Cell Biol. 2018. PMID: 29915025 Free PMC article. Review.
GSH preserves sufficient levels of cysteine and detoxifies xenobiotics while also conferring therapeutic resistance to cancer cells. However, GSH metabolism plays both beneficial and pathogenic roles in a variety of malignancies. ...In this review, we discuss recent studie …
GSH preserves sufficient levels of cysteine and detoxifies xenobiotics while also conferring therapeutic resistance to cancer cells. …
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer.
Jairath NK, Dal Pra A, Vince R Jr, Dess RT, Jackson WC, Tosoian JJ, McBride SM, Zhao SG, Berlin A, Mahal BA, Kishan AU, Den RB, Freedland SJ, Salami SS, Kaffenberger SD, Pollack A, Tran P, Mehra R, Morgan TM, Weiner AB, Mohamad O, Carroll PR, Cooperberg MR, Karnes RJ, Nguyen PL, Michalski JM, Tward JD, Feng FY, Schaeffer EM, Spratt DE. Jairath NK, et al. Eur Urol. 2021 Mar;79(3):374-383. doi: 10.1016/j.eururo.2020.11.021. Epub 2020 Dec 5. Eur Urol. 2021. PMID: 33293078 Review.
J Natl Cancer Inst 2009;101:1446-52) and American Urology Association (AUA) criteria. ...PATIENT SUMMARY: In this paper, we review the evidence of the Decipher genomic classification tool for men with prostate cancer. We found consistent evidence that the test helps …
J Natl Cancer Inst 2009;101:1446-52) and American Urology Association (AUA) criteria. ...PATIENT SUMMARY: In this paper, we review th …
Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study.
Hauptmann M, Byrnes G, Cardis E, Bernier MO, Blettner M, Dabin J, Engels H, Istad TS, Johansen C, Kaijser M, Kjaerheim K, Journy N, Meulepas JM, Moissonnier M, Ronckers C, Thierry-Chef I, Le Cornet L, Jahnen A, Pokora R, Bosch de Basea M, Figuerola J, Maccia C, Nordenskjold A, Harbron RW, Lee C, Simon SL, Berrington de Gonzalez A, Schüz J, Kesminiene A. Hauptmann M, et al. Lancet Oncol. 2023 Jan;24(1):45-53. doi: 10.1016/S1470-2045(22)00655-6. Epub 2022 Dec 6. Lancet Oncol. 2023. PMID: 36493793
Participants were linked with national or regional registries of cancer and vital status, and eligible cases were patients with brain cancers according to WHO International Classification of Diseases for Oncology. ...FUNDING: EU FP7; Belgian Cancer Registry; …
Participants were linked with national or regional registries of cancer and vital status, and eligible cases were patients with brain …
Osteocytes and Cancer.
Pin F, Prideaux M, Bonewald LF, Bonetto A. Pin F, et al. Curr Osteoporos Rep. 2021 Dec;19(6):616-625. doi: 10.1007/s11914-021-00712-9. Epub 2021 Nov 13. Curr Osteoporos Rep. 2021. PMID: 34773212 Free PMC article. Review.
PURPOSE OF REVIEW: While the function of osteocytes under physiologic conditions is well defined, their role and involvement in cancer disease remains relatively unexplored, especially in a context of non-bone metastatic cancer. ...Mechanisms responsible for canc …
PURPOSE OF REVIEW: While the function of osteocytes under physiologic conditions is well defined, their role and involvement in cancer …
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.
Dum D, Menz A, Völkel C, De Wispelaere N, Hinsch A, Gorbokon N, Lennartz M, Luebke AM, Hube-Magg C, Kluth M, Fraune C, Möller K, Bernreuther C, Lebok P, Clauditz TS, Jacobsen F, Sauter G, Uhlig R, Wilczak W, Steurer S, Minner S, Marx AH, Simon R, Burandt E, Krech T. Dum D, et al. Exp Mol Pathol. 2022 Jun;126:104762. doi: 10.1016/j.yexmp.2022.104762. Epub 2022 Apr 4. Exp Mol Pathol. 2022. PMID: 35390310 Free article.
CK20 predominated in gastrointestinal tract, urothelial and Merkel cell carcinomas. CK7 was usually negative in prostate cancer and colorectal cancer. Combined evaluation of CK7/CK20 revealed the best diagnostic utility in CK20 positive tumors, where CK7 negativity …
CK20 predominated in gastrointestinal tract, urothelial and Merkel cell carcinomas. CK7 was usually negative in prostate cancer and c …
Dichotomous colorectal cancer behaviour.
Aljama S, Lago EP, Zafra O, Sierra J, Simón D, Santos C, Pascual JR, Garcia-Romero N. Aljama S, et al. Crit Rev Oncol Hematol. 2023 Sep;189:104067. doi: 10.1016/j.critrevonc.2023.104067. Epub 2023 Jul 15. Crit Rev Oncol Hematol. 2023. PMID: 37454703 Free article. Review.
Colorectal cancer (CRC) is the third most common malignant tumor and one of the deadliest cancers. ...
Colorectal cancer (CRC) is the third most common malignant tumor and one of the deadliest cancers. ...
NCCN Guidelines Insights: Biliary Tract Cancers, Version 2.2023.
Benson AB, D'Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, Anders R, Are C, Bachini M, Binder D, Borad M, Bowlus C, Brown D, Burgoyne A, Castellanos J, Chahal P, Cloyd J, Covey AM, Glazer ES, Hawkins WG, Iyer R, Jacob R, Jennings L, Kelley RK, Kim R, Levine M, Palta M, Park JO, Raman S, Reddy S, Ronnekleiv-Kelly S, Sahai V, Singh G, Stein S, Turk A, Vauthey JN, Venook AP, Yopp A, McMillian N, Schonfeld R, Hochstetler C. Benson AB, et al. J Natl Compr Canc Netw. 2023 Jul;21(7):694-704. doi: 10.6004/jnccn.2023.0035. J Natl Compr Canc Netw. 2023. PMID: 37433432
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care …
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary …
NCCN Guidelines Insights: Central Nervous System Cancers, Version 2.2022.
Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, Brem S, Butowski N, Cannon DM, Chao S, Chheda MG, Fabiano AJ, Forsyth P, Gigilio P, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, Merrell R, Mrugala MM, Nagpal S, Nedzi LA, Nevel K, Nghiemphu PL, Parney I, Patel TR, Peters K, Puduvalli VK, Rockhill J, Rusthoven C, Shonka N, Swinnen LJ, Weiss S, Wen PY, Willmarth NE, Bergman MA, Darlow S. Horbinski C, et al. J Natl Compr Canc Netw. 2023 Jan;21(1):12-20. doi: 10.6004/jnccn.2023.0002. J Natl Compr Canc Netw. 2023. PMID: 36634606
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of the following adult CNS cancers: glioma (WHO grade 1, WHO grade 2-3 oligodendroglioma [1p19q codeleted, IDH-mutant], WHO grade 2-4 IDH-mutant astrocytoma, WHO grade 4 glioblastoma), …
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of the following adult CNS cancers: glioma (W …
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA, D'Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Farjah F, Gerdes H, Gibson M, Grierson P, Hofstetter WL, Ilson DH, Jalal S, Keswani RN, Kim S, Kleinberg LR, Klempner S, Lacy J, Licciardi F, Ly QP, Matkowskyj KA, McNamara M, Miller A, Mukherjee S, Mulcahy MF, Outlaw D, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian NR, Pluchino LA. Ajani JA, et al. J Natl Compr Canc Netw. 2023 Apr;21(4):393-422. doi: 10.6004/jnccn.2023.0019. J Natl Compr Canc Netw. 2023. PMID: 37015332
Cancers originating in the esophagus or esophagogastric junction constitute a major global health problem. ...Palliative management, which may include systemic therapy, chemoradiation, and/or best supportive care, is recommended for all patients with unresectable or metast …
Cancers originating in the esophagus or esophagogastric junction constitute a major global health problem. ...Palliative management, …
13,581 results
You have reached the last available page of results. Please see the User Guide for more information.